講演・口頭発表等 - 玉村　啓和

1. Tamamura H. Prevention of the Spread of Virus Infection in Global Societies: Antiviral Agents from HIV to SARS-CoV-2. Frontiers2026 Symposium on NanoBioEngineering – EPFL 2026.01.14 Lausanne, Switzerland

2. Yamamoto K, Kobayakawa T, Fukutome A, Arioka M, Tsuji K, Tamamura H. Synthesis of peptidomimetics based on a chloroalkene structure and their application in drug discovery. Pacifichem 2025 2025.12.17 Honolulu, Hawaii

3. Miura Y, Tsuji K, Kobayakawa T, Matsumoto K, Kuwata T, Ito Y, YoshiyaT, Matsushita S, Tamamura H . Development of antibody drug conjugates as HIV entry inhibitors. Pacifichem 2025 2025.12.16 Honolulu, Hawaii

4. Tamamura H. Development of antibody-drug-conjugates (ADCs) as anti-HIV agents. Pacifichem 2025 2025.12.15 Honolulu, Hawaii

5. Tamamura H. Antiviral agents from HIV to SARS-CoV-2: prevention of the spread of virus infection in global societies. Pacifichem 2025 2025.12.15 Honolulu, Hawaii

6. Huang X, Tsuji K, Miyamoto M, Yokoo H, Demizu Y, Tamamura H. Development of Novel BRD4 Degraders Using HIV-1 Vpr-derived Peptides as E3 Ligase Ligands. 10th Annual Peptides and Proteins Symposium Singapore 2025.12.09 Singapore

7. Miura Y, Tsuji K, Kobayakawa T, Matsumoto K, Kuwata T, Ito Y, YoshiyaT, Matsushita S, Tamamura H. CD4 Mimic-neutralizing Antibody Conjugates for HIV Entry Inhibitors. 10th Annual Peptides and Proteins Symposium Singapore 2025.12.08 Singapore

8. Kobayakawa T, Yamamoto K, Arioka M, Fukutome A, Tsuji K, Tamamura H. Development of synthetic strategies for peptidomimetics based on haloalkene dipeptide isosteres and their application to cyclic peptides. Solid Phase 2025 2025.10.25 Fukuoka

9. Tsuji K. Development of peptide-based bivalent molecules for medicinal chemistry. The 62nd Japanese Peptide Symposium 2025.10.23 Fukuoka

10. Arioka M, Kobayakawa T, Tsuji K, Tamamura H. Diastereoselective synthesis of fluoroalkene dipeptide isosteres as peptidomimetics and their applications to amyloid beta-related peptides . The 62nd Japanese Peptide Symposium 2025.10.21 Fukuoka

11. Miura Y, Tsuji K, Kobayakawa T, Matsumoto K, Kuwata T, Ito Y, Yoshiya T, Matsushita S, Tamamura H. Antibody-drug conjugates for suppression of HIV entry. The 62nd Japanese Peptide Symposium 2025.10.21 Fukuoka

12. Yamamoto K, Kobayakawa T, Fukutome A, Arioka M, Tsuji K, Tamamura H. Synthesis of Chloroalkene-Based Paptidomimetics and Their Application as Amyloid-Beta Aggregation Inhibitors. 16th Australian Peptide Conference 2025.10.13 Tasmania, Australia

13. Tamamura H. Antibody-Drug-Conjugates (ADCs) for Block of HIV Entry. 16th Australian Peptide Conference 2025.10.12 Tasmania, Australia

14. Yamamoto K, Kobayakawa T, Fukutome A, Arioka M, Tsuji K, Tamamura H. Design and Synthesis of a C2-Symmetric Cyclic Decapeptide and Its Peptidomimetic as Potential Inhibitors against Amyloid-beta Aggregation. 15th International Medicinal Chemistry Symposium 2025.09.25 Hangzhou, China

15. Tamamura H. Development of Antibody-Drug-Conjugates (ADCs) Targeted to HIV Entry. the 15th AFMC International Medicinal Chemistry Symposium (AIMECS 2025) 2025.09.25 Hangzhou, China

16. Arioka M, Kobayakawa T, Tsuji K, Tamamura H. Development of a Synthetic Strategy for Fluoroalkene Dipeptide Isosteres as Peptidomimetics and their Application. 28th Korean Peptide Protein Symposium 2025.06.23 Jeju, South Korea

17. Yamamoto K, Kobayakawa T, Tsuji K, Tamamura H. Chloroalkene-type Dipeptide Isosteres Applicated for Amyloid-beta Aggregation Inhibitors. 29th American Peptide Symposium and 15th International Peptide Symposium 2025.06.17 San Diego, USA

18. Miura Y, Tsuji K, Kobayakawa T, Kuwata T, Matsushita S, Yoshiya T, Ito Y, Tamamura H. Anti-HIV Agent-based Antibody-Drug-Conjugates (ADCs). 29th American Peptide Symposium and 15th International Peptide Symposium 2025.06.16 San Diego, USA

19. Shinohara K, Kobayakawa T, Takamatsu Y, Tsuji K, Mitsuya H, Tamamura H. Development of novel SARS-CoV-2 papain-like protease inhibitors and their application as Mpox I7L protease inhibitors. 29th American Peptide Symposium and 15th International Peptide Symposium 2025.06.16 San Diego, USA

20. Tamamura H. Antibody-Drug-Conjugates (ADCs) containing anti-HIV agents . The 20th Akabori Conference: Japanese-German Symposium on Peptide Science 2025.05.27 Potsdam and Berlin, Germany